CAN TEMOZOLOMIDE EXTEND SURVIVAL OF DIFFUSE INTRINSIC BRAINSTEM GLIOMAS?

Basit Öğe Kaydı
dc.contributor.authorKamer, S.
dc.contributor.authorMutluer, S.
dc.contributor.authorAnacak, Y.
dc.contributor.authorKantar, M.
dc.contributor.authorCetingul, N.
dc.contributor.authorErsahin, Y.
dc.date.accessioned2019-10-27T21:15:28Z
dc.date.available2019-10-27T21:15:28Z
dc.date.issued2010
dc.departmentEge Üniversitesien_US
dc.identifier.endpageS370en_US
dc.identifier.issn0167-8140
dc.identifier.issn1879-0887
dc.identifier.startpageS370en_US
dc.identifier.urihttps://hdl.handle.net/11454/43540
dc.identifier.volume96en_US
dc.identifier.wosWOS:000433351602393en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofRadiotherapy and Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleCAN TEMOZOLOMIDE EXTEND SURVIVAL OF DIFFUSE INTRINSIC BRAINSTEM GLIOMAS?en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu